Activation of hypoxia-inducible factors prevents diabetic nephropathy

Journal of the American Society of Nephrology

Volumn 26, Issue 2, 2015, Pages 328-338

  Nordquist, Lina ^a   Friederich Persson, Malou ^a   Fasching, Angelica ^a   Liss, Per ^a   Shoji, Kumi ^b   Nangaku, Masaomi ^b   Hansell, Peter ^a   Palm, Fredrik ^a,c  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF TOKYO   (Japan)

^c LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; COBALT CHLORIDE; COPPER ZINC SUPEROXIDE DISMUTASE; ERYTHROPOIETIN; HEME OXYGENASE 1; HYPOXIA INDUCIBLE FACTOR; MESSENGER RNA; TEMPOL; UNCOUPLING PROTEIN 2; VASCULOTROPIN; VIMENTIN; AMINE OXIDE; ANTIOXIDANT; COBALT; HYPOXIA INDUCIBLE FACTOR 1; SPIN LABEL;

ACUTE DRUG ADMINISTRATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GLOMERULUS FILTRATION RATE; HEMATOCRIT; HYPOXEMIA; KIDNEY; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY MASS; KIDNEY VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE STRESS; OXYGEN CONSUMPTION; OXYGEN TENSION; PRIORITY JOURNAL; PROTEINURIA; RAT; SODIUM TRANSPORT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; URINE FLOW RATE; ANIMAL; COMPLICATION; DIABETIC NEPHROPATHIES; DISEASE MODEL; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SPIN LABELS; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIOXIDANTS; COBALT; CYCLIC N-OXIDES; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; GLOMERULAR FILTRATION RATE; HYPOXIA-INDUCIBLE FACTOR 1; KIDNEY; MALE; OXIDATIVE STRESS; OXYGEN CONSUMPTION; RATS; RATS, SPRAGUE-DAWLEY; SPIN LABELS;

EID: 84923880080     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013090990     Document Type: Article

References (44)

1. Nangaku M: Chronic hypoxia and tubulointerstitial injury: A final common pathway to end-stage renal failure. J Am Soc Nephrol 17: 17-25, 2006
2. Hansell P, Welch WJ, Blantz RC, Palm F: Determinants of kidney oxygen consumption and their relationship to tissue oxygen tension in diabetes and hypertension. Clin Exp Pharmacol Physiol 40: 123-137, 2013
3. Palm F, Hansell P, Ronquist G, Waldenström A, Liss P, Carlsson PO: Polyol-pathway-dependent disturbances in renal medullary metabolism in experimental insulin-deficient diabetes mellitus in rats. Diabetologia 47: 1223-1231, 2004
4. Palm F, Cederberg J, Hansell P, Liss P, Carlsson PO: Reactive oxygen species cause diabetes-induced decrease in renal oxygen tension. Diabetologia 46: 1153-1160, 2003
5. Friederich-Persson M, Thörn E, Hansell P, Nangaku M, Levin M, Palm F: Kidney hypoxia, attributable to increased oxygen consumption, induces nephropathy independently of hyperglycemia and oxidative stress. Hypertension 62: 914-919, 2013
6. Semenza GL, Wang GL: A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 12: 5447-5454, 1992
7. Leonard MO, Cottell DC, Godson C, Brady HR, Taylor CT: The role of HIF-1 alpha in transcriptional regulation of the proximal tubular epithelial cell response to hypoxia. J Biol Chem 278: 40296-40304, 2003
8. Haase VH: Hypoxia-inducible factors in the kidney. Am J Physiol Renal Physiol 291: F271-F281, 2006
9. Maxwell P: HIF-1: An oxygen response systemwith special relevance to the kidney. J Am Soc Nephrol 14: 2712-2722, 2003
10. Thangarajah H, Yao D, Chang EI, Shi Y, Jazayeri L, Vial IN, Galiano RD, Du XL, Grogan R, Galvez MG, Januszyk M, Brownlee M, Gurtner GC: The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues. Proc Natl Acad Sci U S A 106: 13505-13510, 2009
11. Rosenberger C, Khamaisi M, Abassi Z, Shilo V, Weksler-Zangen S, Goldfarb M, Shina A, Zibertrest F, Eckardt KU, Rosen S, Heyman SN: Adaptation to hypoxia in the diabetic rat kidney. Kidney Int 73: 34-42, 2008
12. Yang ZZ, Zhang AY, Yi FX, Li PL, Zou AP: Redox regulation of HIF-1alpha levels and HO-1 expression in renal medullary interstitial cells. Am J Physiol Renal Physiol 284: F1207-F1215, 2003
13. Echtay KS, Roussel D, St-Pierre J, Jekabsons MB, Cadenas S, Stuart JA, Harper JA, Roebuck SJ, Morrison A, Pickering S, Clapham JC, Brand MD: Superoxide activates mitochondrial uncoupling proteins. Nature 415: 96-99, 2002
14. Echtay KS, Murphy MP, Smith RA, Talbot DA, Brand MD: Superoxide activates mitochondrial uncoupling protein 2 from the matrix side. Studies using targeted antioxidants. J Biol Chem 277: 47129-47135, 2002
15. Persson MF, Franzén S, Catrina SB, Dallner G, Hansell P, Brismar K, Palm F: Coenzyme Q10 prevents GDP-sensitive mitochondrial uncoupling, glomerular hyperfiltration and proteinuria in kidneys from db/db mice as a model of type 2 diabetes. Diabetologia 55: 1535-1543, 2012
16. Friederich M, Fasching A, Hansell P, Nordquist L, Palm F: Diabetes-induced up-regulation of uncoupling protein-2 results in increased mitochondrial uncoupling in kidney proximal tubular cells. Biochim Biophys Acta 1777: 935-940, 2008
17. Semenza GL: Transcriptional regulation of gene expression: Mechanisms and pathophysiology. Hum Mutat 3: 180-199, 1994
18. Norman JT, Fine LG: Intrarenal oxygenation in chronic renal failure. Clin Exp Pharmacol Physiol 33: 989-996, 2006
19. Kimura K, Iwano M, Higgins DF, Yamaguchi Y, Nakatani K, Harada K, Kubo A, Akai Y, Rankin EB, Neilson EG, Haase VH, Saito Y: Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fi brosis. Am J Physiol Renal Physiol 295: F1023-F1029, 2008
20. Rudnicki M, Perco P, Enrich J, Eder S, Heininger D, Bernthaler A, Wiesinger M, Sarkozi R, Noppert SJ, Schramek H, Mayer B, Oberbauer R, Mayer G: Hypoxia response and VEGF-A expression in human proximal tubular epithelial cells in stable and progressive renal disease. Lab Invest 89: 337-346, 2009
21. Bahlmann FH, Song R, Boehm SM, Mengel M, von Wasielewski R, Lindschau C, Kirsch T, de Groot K, Laudeley R, Niemczyk E, Güler F, Menne J, Haller H, Fliser D: Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure. Circulation 110: 1006-1012, 2004
22. Eto N, Wada T, Inagi R, Takano H, Shimizu A, Kato H, Kurihara H, Kawachi H, Shankland SJ, Fujita T, Nangaku M: Podocyte protection by darbepoetin: Preservation of the cytoskeleton and nephrin expression. Kidney Int 72: 455-463, 2007
23. Masuda Y, Shimizu A, Mori T, Ishiwata T, Kitamura H, Ohashi R, Ishizaki M, Asano G, Sugisaki Y, Yamanaka N: Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Am J Pathol 159: 599-608, 2001
24. Katavetin P, Inagi R, Miyata T, Shao J, Sassa R, Adler S, Eto N, Kato H, Fujita T, Nangaku M: Erythropoietin induces heme oxygenase-1 expression and attenuates oxidative stress. Biochem Biophys Res Commun 359: 928-934, 2007
25. DeRubertis FR, Craven PA, Melhem MF, Salah EM: Attenuation of renal injury in db/db mice overexpressing superoxide dismutase: Evidence for reduced superoxide-nitric oxide interaction. Diabetes 53: 762-768, 2004
26. Song YR, You SJ, Lee YM, Chin HJ, Chae DW, Oh YK, Joo KW, Han JS, Na KY: Activation of hypoxia-inducible factor attenuates renal injury in rat remnant kidney. Nephrol Dial Transplant 25: 77-85, 2010
27. Ohtomo S, Nangaku M, Izuhara Y, Takizawa S, Strihou C, Miyata T: Cobalt ameliorates renal injury in an obese, hypertensive type 2 diabetes rat model. Nephrol Dial Transplant 23: 1166-1172, 2008
28. Rodríguez-Iturbe B, Johnson RJ, Herrera-Acosta J: Tubulointerstitial damage and progression of renal failure. Kidney Int Suppl 99: S82-S86, 2005
29. Risdon RA, Sloper JC, De Wardener HE: Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. Lancet 2: 363-366, 1968
30. Gilbert RE, Cooper ME: The tubulointerstitium in progressive diabetic kidney disease:More than an aftermath of glomerular injury? Kidney Int 56: 1627-1637, 1999
31. Mobasheri A, Platt N, Thorpe C, Shakibaei M: Regulation of 2-deoxy-D-glucose transport, lactate metabolism, and MMP-2 secretion by the hypoxia mimetic cobalt chloride in articular chondrocytes. Ann N Y Acad Sci 1091: 83-93, 2006
32. Telib M, Schmidt FH: Effect of cobaltous chloride in laboratory animals. II. Effect on blood sugar, plasma insulin and plasma lipids in rabbits. Endokrinologie 61: 395-402, 1973
33. Vasudevan H, McNeill JH: Chronic cobalt treatment decreases hyperglycemia in streptozotocin-diabetic rats. Biometals 20: 129-134, 2007
34. Moreno JM, Rodríguez Gómez I, Wangensteen R, Alvarez-Guerra M, de Dios Luna J, García-Estañ J, Vargas F: Tempol improves renal hemodynamics and pressure natriuresis in hyperthyroid rats. Am J Physiol Regul Integr Comp Physiol 294: R867-R873, 2008
35. Schnackenberg CG, Welch WJ, Wilcox CS: Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: Role of nitric oxide. Hypertension 32: 59-64, 1998
36. Yanes L, Romero D, Iliescu R, Cucchiarelli VE, Fortepiani LA, Santacruz F, Bell W, Zhang H, Reckelhoff JF: Systemic arterial pressure response to two weeks of Tempol therapy in SHR: Involvement of NO, the RAS, and oxidative stress. Am J Physiol Regul Integr Comp Physiol 288: R903-R908, 2005
37. Guron GS, Grimberg ES, Basu S, Herlitz H: Acute effects of the superoxide dismutase mimetic tempol on split kidney function in two-kidney one-clip hypertensive rats. J Hypertens 24: 387-394, 2006
38. Luan J, Li W, Han J, Zhang W, Gong H, Ma R: Renal protection of in vivo administration of tempol in streptozotocin-induced diabetic rats. J Pharmacol Sci 119: 167-176, 2012
39. Palm F, Nordquist L: Renal oxidative stress, oxygenation, and hypertension. Am J Physiol Regul Integr Comp Physiol 301: R1229-R1241, 2011
40. Chen X, Patel K, Connors SG, Mendonca M, Welch WJ, Wilcox CS: Acute antihypertensive action of Tempol in the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol 293: H3246-H3253, 2007
41. Tanaka T, Matsumoto M, Inagi R, Miyata T, Kojima I, Ohse T, Fujita T, Nangaku M: Induction of protective genes by cobalt ameliorates tubulointerstitial injury in the progressive Thy1 nephritis. Kidney Int 68: 2714-2725, 2005
42. Son D, Kojima I, Inagi R, Matsumoto M, Fujita T, Nangaku M: Chronic hypoxia aggravates renal injury via suppression of Cu/Zn-SOD: A proteomic analysis. Am J Physiol Renal Physiol 294: F62-F72, 2008
43. Matsumoto M, Makino Y, Tanaka T, Tanaka H, Ishizaka N, Noiri E, Fujita T, Nangaku M: Induction of renoprotective gene expression by cobalt ameliorates ischemic injury of the kidney in rats. J Am Soc Nephrol 14: 1825-1832, 2003
44. Friederich-Persson M, Aslam S, Nordquist L, Welch WJ, Wilcox CS, Palm F: Acute knockdown of uncoupling protein-2 increases uncoupling via the adenine nucleotide transporter and decreases oxidative stress in diabetic kidneys. PLoS ONE 7: e39635, 2012